COMMUNIQUÉ DE PRESSE publié le 26/02/2024 à 14:00, il y a 1 année 11 mois FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM) FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRÈVE publiée le 26/02/2024 à 14:00, il y a 1 année 11 mois FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™ FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
BRÈVE publiée le 26/02/2024 à 14:00, il y a 1 année 11 mois FSD Pharma lance un essai clinique pour tester l'efficacité d'unbuzzd™ FSD Pharma Essai Clinique Unbuzzd™ Métabolisme De L'alcool Sobriété Accélérée
COMMUNIQUÉ DE PRESSE publié le 17/02/2024 à 01:10, il y a 1 année 11 mois FSD Pharma Announces US ATM Offering FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 13:00, il y a 1 année 11 mois Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
COMMUNIQUÉ DE PRESSE publié le 29/01/2024 à 22:30, il y a 2 années FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:30, il y a 2 années Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics. Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
COMMUNIQUÉ DE PRESSE publié le 23/12/2023 à 01:45, il y a 2 années 1 mois FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 15:00, il y a 2 années 1 mois FSD Pharma Inc. Announces Closing of Private Placement FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
COMMUNIQUÉ DE PRESSE publié le 30/11/2023 à 14:30, il y a 2 années 2 mois FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities
Publié le 04/02/2026 à 18:04, il y a 11 heures 50 minutes Capital et droits de vote au 31 janvier 2026
Publié le 04/02/2026 à 18:04, il y a 11 heures 50 minutes Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 12 heures 9 minutes Information concerning the total number of voting rights and shares 2026 01 31
Publié le 04/02/2026 à 17:45, il y a 12 heures 9 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/02/2026 à 01:35, il y a 4 heures 19 minutes Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Publié le 05/02/2026 à 00:00, il y a 5 heures 54 minutes Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Publié le 04/02/2026 à 22:25, il y a 7 heures 29 minutes 55 North Mining Announces Flow-Through Financing
Publié le 04/02/2026 à 16:15, il y a 13 heures 39 minutes Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Publié le 04/02/2026 à 20:54, il y a 9 heures Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Publié le 04/02/2026 à 20:36, il y a 9 heures 18 minutes EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Publié le 04/02/2026 à 20:00, il y a 9 heures 54 minutes Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Publié le 04/02/2026 à 18:55, il y a 10 heures 59 minutes Funding Circle Holdings plc: POS-Transaction in Own Shares
Publié le 04/02/2026 à 18:40, il y a 11 heures 14 minutes Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology